MedPath

Effects of Projected Peripheral Defocus on Ocular Biometrics

Not Applicable
Completed
Conditions
Myopia
Registration Number
NCT04388020
Lead Sponsor
Kubota Vision Inc.
Brief Summary

Acucela Inc. intends to develop a medical device to significantly halt or reverse myopic progression, which is a significant public health concern across the world, especially in Asian demographics. Acucela is working towards a spectacle-like device (eSPECs), which will have a clear zone for unimpeded central visual tasks and a periphery that provides defocus in order to alter retinal physiology leading to myopia regulation. This study will establish the changes seen during a proof-of-concept that projected defocus in the periphery will stimulate physiological changes similar to those in the literature.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Spherical equivalent +2.00 to -4.00 diopters
  • Refractive cylinder ≤ 0.75 diopters
  • Visual acuity 20/20 -3 or better
Exclusion Criteria
  • Pregnant or lactating
  • Active ocular infection
  • History of dry eye, strabismus, or amblyopia
  • Previous or planned ocular surgery
  • Use of medication known to affect vision or accommodation

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Axial length (AL)1 hour

Change in AL from baseline in the test eye vs. control eye

Choroidal thickness (CT)1 hour

Change in CT from baseline in the test eye vs. control eye

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Manhattan Vision Associates/institute of Vision Research

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath